This is the final version. Available on open access from BMJ Publishing Group via the DOI in this recordData availability statement: All data relevant to the study are included in the article or uploaded as online supplemental information. All research data supporting this publication are provided within this article.Background Missed opportunities for diagnosing cancer cause patients harm and have been attributed to suboptimal use of tests and referral pathways in primary care. Primary care physician (PCP) factors have been suggested to affect decisions to investigate cancer, but their influence is poorly understood. Objective To synthesise evidence evaluating the influence of PCP factors on decisions to investigate symptoms of possibl...
Cancer risk assessment tools for symptomatic individuals presenting to primary care: a systematic sc...
Objective: This scoping review aims to understand the currently available evidence on patient-relate...
Objectives Cancer survival and stage of disease at diagnosis and treatment vary widely across Europe...
BACKGROUND: Missed opportunities for diagnosing cancer cause patients harm and have been attributed ...
PublishedJournal ArticleResearch Support, Non-U.S. Gov'tBACKGROUND: This paper reviews the backgroun...
Background Symptom recognition and timely referral in primary care are crucial for the early diagno...
ALN is supported by the National Institute for Health Research (NIHR) Imperial Patient Safety Transl...
This is the final published version. Available from Springer Nature via the DOI in this record.Backg...
BACKGROUND While Primary Care Physicians (PCPs) play a key role in cancer detection, they can fin...
OBJECTIVES Cancer survival and stage of disease at diagnosis and treatment vary widely across Eur...
This is the final published version. Available from the Royal College of General Practitioners via t...
Background: For patients with symptoms of possible cancer who do not fulfil the criteria for urgent ...
Objectives Cancer survival and stage of disease at diagnosis and treatment vary widely across Europe...
Genomic tests are being developed for use in cancer screening. As most screening is offered in prima...
Objectives Cancer survival and stage of disease at diagnosis and treatment vary widely across Europe...
Cancer risk assessment tools for symptomatic individuals presenting to primary care: a systematic sc...
Objective: This scoping review aims to understand the currently available evidence on patient-relate...
Objectives Cancer survival and stage of disease at diagnosis and treatment vary widely across Europe...
BACKGROUND: Missed opportunities for diagnosing cancer cause patients harm and have been attributed ...
PublishedJournal ArticleResearch Support, Non-U.S. Gov'tBACKGROUND: This paper reviews the backgroun...
Background Symptom recognition and timely referral in primary care are crucial for the early diagno...
ALN is supported by the National Institute for Health Research (NIHR) Imperial Patient Safety Transl...
This is the final published version. Available from Springer Nature via the DOI in this record.Backg...
BACKGROUND While Primary Care Physicians (PCPs) play a key role in cancer detection, they can fin...
OBJECTIVES Cancer survival and stage of disease at diagnosis and treatment vary widely across Eur...
This is the final published version. Available from the Royal College of General Practitioners via t...
Background: For patients with symptoms of possible cancer who do not fulfil the criteria for urgent ...
Objectives Cancer survival and stage of disease at diagnosis and treatment vary widely across Europe...
Genomic tests are being developed for use in cancer screening. As most screening is offered in prima...
Objectives Cancer survival and stage of disease at diagnosis and treatment vary widely across Europe...
Cancer risk assessment tools for symptomatic individuals presenting to primary care: a systematic sc...
Objective: This scoping review aims to understand the currently available evidence on patient-relate...
Objectives Cancer survival and stage of disease at diagnosis and treatment vary widely across Europe...